Hagop Youssoufian

age ~68

from Princeton, NJ

Also known as:
  • Hagop N
Phone and address:
267 Dodds Ln, Princeton, NJ 08540
6096880504

Hagop Youssoufian Phones & Addresses

  • 267 Dodds Ln, Princeton, NJ 08540 • 6096880504 • 6096881785
  • Boston, MA
  • 3418 Rice Ave, Houston, TX 77005 • 2812180106 • 7136677794
  • West University Place, TX
  • 52 Edgecliff Rd, Watertown, MA 02472
  • Lawrenceville, NJ
  • 14 Curlew St, West Roxbury, MA 02132 • 6097804717

Work

  • Company:
    Bind therapeutics
    Nov 1, 2014 to Aug 2016
  • Position:
    Chief medical officer

Education

  • School / High School:
    Harvard Medical School
    1987 to 1991

Skills

Clinical Trials • Medical Writing • Translational Medicine • Cro • Cardiology • Clinical Pharmacology • Neuroscience • Medical Education • Neurology • Infectious Diseases • Genomics • Clinical Research • Ctms • Biotechnology • Immunology • Healthcare • Life Sciences • Hematology • Internal Medicine • Pharmacovigilance • Drug Discovery • Molecular Biology • Lifesciences • Medicine • Oncology • Drug Development • Gcp • Clinical Development • Pharmaceutics • Edc • Vaccines • Cancer • Regulatory Submissions • Pharmacology • Pharmaceutical Industry • Science • Biochemistry • Therapeutic Areas • Biomarkers • R&D • Fda • Sop • Commercialization • Medical Affairs • Biopharmaceuticals

Industries

Biotechnology
Name / Title
Company / Classification
Phones & Addresses
Hagop Youssoufian
President, Research And Development Staff
Ziopharm Oncology
Pharmaceuticals · Development Stage Company Engaged In The Development and Commercialization of A Portfolio of In-Licensed Cancer Drugs · Development Stage Company In Development and Commercialization of A Portfolio of In-Licensed Cancer Drugs · Pharmaceutical Preparations · Mfg Pharmaceutical Preparations
1 1 Avenue, Parris BUILDING #34, Boston, MA 02129
1180 Ave Of The, New York, NY 10036
1180 Ave, New York, NY 10036
1 1 Ave, Boston, MA 02129
6462140700

Resumes

Hagop Youssoufian Photo 1

Consultant To Biotech Industry

view source
Location:
267 Dodds Ln, Princeton, NJ 08540
Industry:
Biotechnology
Work:
Bind Therapeutics Nov 1, 2014 - Aug 2016
Chief Medical Officer

Progenics Pharmaceuticals Jul 2013 - Sep 2014
Executive Vice President

Ziopharm Oncology Oct 2011 - Apr 2013
President of R and D and Chief Medical Officer

Independent Consultant Oct 2011 - Apr 2013
Consultant To Biotech Industry

Ziopharm Oncology Jul 2011 - Sep 2011
Chief Marketing Officer and Executive Vice President
Education:
Harvard Medical School 1987 - 1991
Whitehead Institute 1988 - 1991
The Johns Hopkins University School of Medicine 1985 - 1987
University of Massachusetts Medical School 1978 - 1983
Master of Science, Doctorates, Masters, Doctor of Medicine, Medicine
Boston College 1974 - 1978
Bachelors, Bachelor of Science, Biology
Skills:
Clinical Trials
Medical Writing
Translational Medicine
Cro
Cardiology
Clinical Pharmacology
Neuroscience
Medical Education
Neurology
Infectious Diseases
Genomics
Clinical Research
Ctms
Biotechnology
Immunology
Healthcare
Life Sciences
Hematology
Internal Medicine
Pharmacovigilance
Drug Discovery
Molecular Biology
Lifesciences
Medicine
Oncology
Drug Development
Gcp
Clinical Development
Pharmaceutics
Edc
Vaccines
Cancer
Regulatory Submissions
Pharmacology
Pharmaceutical Industry
Science
Biochemistry
Therapeutic Areas
Biomarkers
R&D
Fda
Sop
Commercialization
Medical Affairs
Biopharmaceuticals

Us Patents

  • Combination Therapy Including Isophosphoramide Mustard, Analogs, Or Salts Thereof

    view source
  • US Patent:
    20130196000, Aug 1, 2013
  • Filed:
    Jan 30, 2013
  • Appl. No.:
    13/753975
  • Inventors:
    Jonathan LEWIS - Fairfield CT, US
    Hagop YOUSSOUFIAN - West Roxbury MA, US
  • Assignee:
    ZIOPHARM ONCOLOGY, INC. - Boston MA
  • International Classification:
    A61K 31/7048
    A61K 31/555
    A61K 31/664
  • US Classification:
    424649, 514 27
  • Abstract:
    In one aspect, a method for treating a subject having a hyperproliferative disorder is disclosed, including administering to the subject a composition including: IPM, an IPM analog, or a pharmaceutically acceptable salt thereof in the dosage from about 70 mg/m/day to about 160 mg/m/day; etoposide in the dosage up to about 100 mg/m/day; and one or more of carboplatin, cisplatin, oxaliplatin, picoplatin, or a combination thereof in the dosage of from AUC 2 mg/mL/min to AUC 7 mg/mL/min; wherein the treatment does not result in a dose limiting toxicity.

Medicine Doctors

Hagop Youssoufian Photo 2

Hagop Youssoufian

view source
Specialties:
Internal Medicine
Hematology
Medical Oncology
Medical Genetics
Clinical Genetics
M.D.
Education:
University of Massachusetts (1983)

Youtube

Hagop Youssoufian - Developing Accurate Nanom...

Watch on LabRoots at Nanotechnology, the engineering and manufacture...

  • Duration:
    1h 3m 56s

Hagop Mgrdichian & THE BAND - Teguz Ampoghch ...

  • Duration:
    4m 48s

Hagop Yaghljian - Anoushigs //2021// 4K Music...

Singer: Hagop Yaghljian Arrangement, mixing and mastering: Jean Bikand...

  • Duration:
    6m 1s

HAGOP & THE BAND - SERE GYANKE | LIVE 2021

hagopmgrdichian #armeniansinger #armeniansong Facebook: ...

  • Duration:
    4m 21s

Joseph Krikorian & Hagop Yaghljian Ft. Alex &...

This song is a cover of the original song Sevoulig Atcheret Of the leg...

  • Duration:
    3m 32s

HAGOP & THE BAND - DZOVNE SHARACHUM | LIVE 2021

#HagopMgrdichian #ArmenianSong #Armenia #Singer #ArmenianMusic.

  • Duration:
    3m 2s

Get Report for Hagop Youssoufian from Princeton, NJ, age ~68
Control profile